Showing results (161-170 of 169) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 169 results.
Nature Communications|September 8, 2022
Biomarker correlates with response to NY-ESO-1 TCR T cells in patients with synovial sarcomaAlexandra Gyurdieva, Stefan Zajic, Ya-Fang Chang, et al.
JAMA Dermatology|August 16, 2023
Estimated Prevalence, Tumor Spectrum, and Neurofibromatosis Type 1-Like Phenotype of CDKN2A-Related Melanoma-Astrocytoma SyndromeMichael R Sargen, Jung Kim, Thomas P Potjer, et al.
Nature Medicine|May 29, 2012
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through METHéctor Peinado, Maša Alečković, Simon Lavotshkin, et al.
Cancer Research Communications|November 15, 2023
Longitudinal Natural History Study of Children and Adults with Rare Solid Tumors: Initial Results for First 200 ParticipantsShadin Ahmed, Mary Frances Wedekind, Jaydira Del Rivero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2016
MultiDimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A Report from the Center for Cancer ResearchWendy Chang, Andrew S Brohl, Rajesh Patidar, et al.
Nature Communications|July 2, 2025
Identification of the Notch ligand DLK1 as an immunotherapeutic target and regulator of tumor cell plasticity and chemoresistance in adrenocortical carcinomaNai-Yun Sun, Suresh Kumar, Yoo Sun Kim, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 15, 2022
Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trialsKenneth Cornetta, Jing Yao, Kimberley House, et al.
Nature Medicine|January 6, 2025
Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trialAndrea M Gross, Geraldine O'Sullivan Coyne, Eva Dombi, et al.
Cancer Cell|December 22, 2023
Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapySabina Kaczanowska, Tara Murty, Ahmad Alimadadi, et al.
Pageof 17